David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$233M |
| 2 |
Synopsys
SNPS
|
+$218M |
| 3 |
Amazon
AMZN
|
+$217M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$79.7M |
| 5 |
NVIDIA
NVDA
|
+$73.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$367M |
| 2 |
Zscaler
ZS
|
+$75.8M |
| 3 |
GlobalFoundries
GFS
|
+$41.1M |
| 4 |
VTYX
Ventyx Biosciences
VTYX
|
+$9.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 71.65% |
| 2 | Industrials | 10.96% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Healthcare | 4.83% |
| 5 | Materials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$5.2T
| $1.5B | 20.43% |
54,146,000
+3,416,000
| +7% | +$73.9M |
|
|
2
GlobalFoundries
GFS
$26.4B
| $1.29B | 17.5% |
17,848,000
-650,000
| -4% | -$41.1M |
|
3
TransDigm Group
TDG
$66.4B
| $807M | 10.96% |
1,094,900
| – | – |
|
|
ALTR
4
DELISTED
Altair Engineering Inc
ALTR
| $806M | 10.94% |
11,174,200
+303,200
| +3% | +$17.9M |
|
|
5
Applied Materials
AMAT
$391B
| $774M | 10.51% |
6,297,700
+2,028,700
| +48% | +$233M |
|
|
6
Amazon
AMZN
$2.79T
| $758M | 10.29% |
7,335,828
+2,250,828
| +44% | +$217M |
|
7
ASML
ASML
$677B
| $338M | 4.6% |
497,200
| – | – |
|
8
Workday
WDAY
$49.4B
| $328M | 4.45% |
1,586,043
| – | – |
|
|
9
Synopsys
SNPS
$76.2B
| $236M | 3.2% |
+609,735
| New | +$218M |
|
10
Zentalis Pharmaceuticals
ZNTL
$363M
| $158M | 2.15% |
9,199,973
| – | – |
|
|
11
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $106M | 1.44% |
2,564,000
+1,865,200
| +267% | +$79.7M |
|
12
Adaptive Biotechnologies
ADPT
$4.15B
| $102M | 1.39% |
11,572,590
| – | – |
|
13
Perimeter Solutions
PRM
$5.15B
| $60.3M | 0.82% |
7,462,500
| – | – |
|
14
Aura Biosciences
AURA
$809M
| $49.8M | 0.68% |
5,362,870
| – | – |
|
|
ADAP
15
DELISTED
Adaptimmune Therapeutics
ADAP
| $42.5M | 0.58% |
38,974,185
| – | – |
|
|
VTYX
16
DELISTED
Ventyx Biosciences
VTYX
| $3.01M | 0.04% |
89,900
-245,100
| -73% | -$9.53M |
|
|
17
Zscaler
ZS
$29.4B
| $2.15M | 0.03% |
18,405
-631,595
| -97% | -$75.8M |
|
|
18
Qualcomm
QCOM
$169B
| – | – |
-3,337,360
| Closed | -$367M |
|
Similar funds
David Goel's Q1 2023 Portfolio in Review
As of Q1 2023, David Goel held 18 positions worth $7.36B, up 41% from $5.24B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
David Goel deployed $347M of net new capital in Q1 2023, opening 1 new position and adding to 5 existing holdings. Its largest new stake was Synopsys: 609,735 shares worth $236M.
By sector, the portfolio is most concentrated in Technology at 72% of assets, up from 69% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Zscaler, an estimated $75.8M trimmed.
- David Goel's largest Q1 2023 buy was Synopsys: 609,735 shares worth $236M.
- David Goel added most to Applied Materials in Q1 2023, an estimated $233M increase.
- David Goel's biggest Q1 2023 reduction was Zscaler, cutting an estimated $75.8M.
- David Goel fully exited Qualcomm in Q1 2023, selling an estimated $367M.
- David Goel's ten largest holdings make up 95% of its $7.36B portfolio in Q1 2023.
- David Goel opened 1 new position and closed 1 in Q1 2023.
- David Goel's portfolio value rose 41% quarter-over-quarter to $7.36B.
Based on Matrix Capital Management Company's 13F filing for Q1 2023, filed 15 May 2023.